Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Madden

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Microbiology (Reading, England)|November 1, 1996
Organic acid excretion by Streptomyces lividans TK24 during growth on defined carbon and nitrogen sourcesT Madden, J M Ward, A P Ison
Pharmacotherapy|May 1, 1997
The use of microdialysis in pharmacokinetics and pharmacodynamicsM J Johansen, R A Newman, T Madden
Autophagy|April 4, 2007
A calpain-like protease inhibits autophagic cell deathDavid T Madden, Lotti Egger, Dale E Bredesen
Acta Crystallographica. Section D, Biological Crystallography|September 21, 2011
Two-photon excited UV fluorescence for protein crystal detectionJeremy T Madden, Emma L DeWalt, Garth J Simpson
The Analyst|November 16, 2010
Mining the polarization-dependence of nonlinear optical measurementsJeremy T Madden, Victoria J Hall, Garth J Simpson
Journal of Surgical Oncology|January 1, 1994
Nutritional support and prognosis in patients with head and neck cancerM J Lopez, P Robinson, T Madden, et al.
Drug and Alcohol Dependence|August 3, 2020
Antagonizing serotonin 2A (5-HT<sub>2A</sub>) receptors attenuates methamphetamine-induced reward and blocks methamphetamine-induced anxiety-like behaviors in adult male ratsJohn T Madden, Nicole C Reyna, Nathan S Pentkowski
Biochemical Pharmacology|July 13, 2001
Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrinJ A Smith, T Madden, M Vijjeswarapu, et al.
Clinical Pharmacology and Therapeutics|June 1, 1992
The pharmacokinetics of high-dose carboplatin in pediatric patients with cancerT Madden, M Sunderland, V M Santana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Dosing of thioTEPA for myeloablative therapyD Przepiorka, T Madden, C Ippoliti, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Microbiology (Reading, England)|November 1, 1996
Organic acid excretion by Streptomyces lividans TK24 during growth on defined carbon and nitrogen sourcesT Madden, J M Ward, A P Ison
Pharmacotherapy|May 1, 1997
The use of microdialysis in pharmacokinetics and pharmacodynamicsM J Johansen, R A Newman, T Madden
Autophagy|April 4, 2007
A calpain-like protease inhibits autophagic cell deathDavid T Madden, Lotti Egger, Dale E Bredesen
Acta Crystallographica. Section D, Biological Crystallography|September 21, 2011
Two-photon excited UV fluorescence for protein crystal detectionJeremy T Madden, Emma L DeWalt, Garth J Simpson
The Analyst|November 16, 2010
Mining the polarization-dependence of nonlinear optical measurementsJeremy T Madden, Victoria J Hall, Garth J Simpson
Journal of Surgical Oncology|January 1, 1994
Nutritional support and prognosis in patients with head and neck cancerM J Lopez, P Robinson, T Madden, et al.
Drug and Alcohol Dependence|August 3, 2020
Antagonizing serotonin 2A (5-HT<sub>2A</sub>) receptors attenuates methamphetamine-induced reward and blocks methamphetamine-induced anxiety-like behaviors in adult male ratsJohn T Madden, Nicole C Reyna, Nathan S Pentkowski
Biochemical Pharmacology|July 13, 2001
Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrinJ A Smith, T Madden, M Vijjeswarapu, et al.
Clinical Pharmacology and Therapeutics|June 1, 1992
The pharmacokinetics of high-dose carboplatin in pediatric patients with cancerT Madden, M Sunderland, V M Santana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Dosing of thioTEPA for myeloablative therapyD Przepiorka, T Madden, C Ippoliti, et al.
Pageof 9